Home » Topics » Regulatory

Regulatory
RSS

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

VivaGel BV approved in E.U. for bacterial vaginosis

Sep. 25, 2015

LFB's IVIg Iqymune approved in U.K. and Denmark

Sep. 22, 2015

FDA approves Vraylar for bipolar disorder and schizophrenia

Sep. 18, 2015